BRAF and vitamin D deficiency: Further studies are required to investigate the association of severe vitamin D deficiency with BRAF‐mutated melanoma, especially as low vitamin D levels may impact and increase the incidence of immune‐related adverse events in patients receiving immunotherapy (29).